Insulin-like growth factor receptor 1 (IGFR-1) expression is significantly associated with longer survival in non-small cell lung cancer (NSCLC) patients treated with gefitinib

被引：0
|
作者：
Cappuzzo, F.
Ceresoli, G.
Bartolini, S.
Toschi, L.
Finocchiaro, G.
Domenichini, I.
Tallini, G.
Santoro, A.
Crino, L.
Hirsch, F.
机构：
[1] Bellaria Hosp, Bologna, Italy
[2] Ist Clin Humanitas, Milan, Italy
[3] CINECA, Bologna, Italy
[4] Ist Clin Humanitas, Bologna, Italy
[5] Colorado Canc Ctr, Aurora, CO USA
来源：
EJC SUPPLEMENTS | 2005年 / 3卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：335 / 335
页数：1
相关论文
共 50 条
  • [41] Expression of Insulin-Like Growth Factor 1 and Insulin-Like Growth Factor 1 Receptor is Associated with the Favorable Clinicopathologic Parameters in Small Intestinal Carcinomas
    Shin, Hyung Chan
    Bae, Young Kyung
    Gu, Mi Jin
    Jung, Eun Sun
    Oh, Young-Ha
    PATHOBIOLOGY, 2013, 80 (05) : 265 - 270
  • [42] miR-140 Suppresses Tumor Growth and Metastasis of Non-Small Cell Lung Cancer by Targeting Insulin-Like Growth Factor 1 Receptor
    Yuan, Yunfeng
    Shen, Yaxing
    Xue, Liang
    Fan, Hong
    PLOS ONE, 2013, 8 (09):
  • [43] Insulin-like growth factor binding proteins related to progression-free survival (PFS) and overall survival (OS) in advanced non-small cell lung cancer (NSCLC) patients treated with chemotherapy
    Karmali, R.
    Fidler, M. J.
    Cela, I.
    Olmsted, G.
    Rouhi, O.
    Basu, S.
    Walters, K. K.
    Coon, J.
    Bonomi, P.
    Borgia, J. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [44] Inhibition of Insulin-Like Growth Factor 1 Receptor by CP-751,871 Radiosensitizes Non-Small Cell Lung Cancer Cells
    Iwasa, Tsutomu
    Okamoto, Isamu
    Suzuki, Minoru
    Hatashita, Erina
    Yamada, Yuki
    Fukuoka, Masahiro
    Ono, Koji
    Nakagawa, Kazuhiko
    CLINICAL CANCER RESEARCH, 2009, 15 (16) : 5117 - 5125
  • [45] Epidermal growth factor receptor (EGFR) expression in non-small cell lung carcinoma (NSCLC) and survival
    Salimath, Shivalingaswamy
    Jayaraj, B. S.
    Mahesh, P. A.
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [46] Implication of the insulin-like growth factor-IR pathway in the resistance of non-small cell lung cancer cells totreatment with gefitinib
    Morgillo, Floriana
    Kim, Woo-Young
    Kim, Edward S.
    Ciardiello, Fortunato
    Hong, Waun Ki
    Lee, Ho-Young
    CLINICAL CANCER RESEARCH, 2007, 13 (09) : 2795 - 2803
  • [47] Inhibiting Insulin-Like Growth Factor-1 Receptor Attenuates Cell Proliferation and Vascular Endothelial Growth Factor Production in Insulin-Like Growth Factor-1 Receptor Over-Expressing Epidermal Growth Factor Receptor Mutant Non-Small Cell Lung Cancer Cells
    Dong, Yeo Chang
    CHEST, 2017, 152 (04) : 621A - 621A
  • [48] MYC and EIF3H Coamplification Significantly Improve Response and Survival of Non-small Cell Lung Cancer Patients (NSCLC) Treated with Gefitinib
    Cappuzzo, Federico
    Varella-Garcia, Marileila
    Rossi, Elisa
    Gajapathy, Sujatha
    Valente, Marialuisa
    Drabkin, Harry
    Gemmill, Robert
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (04) : 472 - 478
  • [49] Epidermal growth factor receptor mutations in Greek gefitinib-treated non-small-cell lung cancer (NSCLC) patients
    Voutsina, A
    Pallis, AG
    Souglakos, J
    Koutsopoulos, A
    Kalykaki, A
    Trypaki, M
    Mavroudis, D
    Georgoulias, V
    ANNALS OF ONCOLOGY, 2006, 17 : 42 - 42
  • [50] Targeting the insulin-like growth factor receptor and Src signaling network for the treatment of non-small cell lung cancer
    Min, Hye-Young
    Yun, Hye Jeong
    Lee, Ji-Sun
    Lee, Hyo-Jong
    Cho, Jaebeom
    Jang, Hyun-Ji
    Park, Shin-Hyung
    Liu, Diane
    Oh, Seung-Hyun
    Lee, J. Jack
    Wistuba, Ignacio I.
    Lee, Ho-Young
    MOLECULAR CANCER, 2015, 14
12345